000 01316 a2200337 4500
005 20250515063004.0
264 0 _c20070621
008 200706s 0 0 eng d
022 _a1078-0432
024 7 _a10.1158/1078-0432.CCR-06-2793
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTse, Archie N
245 0 0 _aTargeting checkpoint kinase 1 in cancer therapeutics.
_h[electronic resource]
260 _bClinical cancer research : an official journal of the American Association for Cancer Research
_cApr 2007
300 _a1955-60 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aCell Cycle
_xdrug effects
650 0 4 _aCheckpoint Kinase 1
650 0 4 _aClinical Trials as Topic
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aHumans
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aProtein Kinases
_xdrug effects
650 0 4 _aSignal Transduction
_xphysiology
700 1 _aCarvajal, Richard
700 1 _aSchwartz, Gary K
773 0 _tClinical cancer research : an official journal of the American Association for Cancer Research
_gvol. 13
_gno. 7
_gp. 1955-60
856 4 0 _uhttps://doi.org/10.1158/1078-0432.CCR-06-2793
_zAvailable from publisher's website
999 _c16956352
_d16956352